Clinical Trials Browser

Phase 1 × Metastatic Solid Tumors × 90 days × Clear all

NCT06585488 2026-03-18

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Phase 1 Recruiting

GastrointestinalOther solid neoplasmThoracic

Metastatic Solid Tumors

NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors

NCT07108114 2026-02-23

SLV-324 Treatment of Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Metastatic Solid Tumors